Femasys (FEMY) Revenue (2020 - 2025)

Femasys (FEMY) posted Revenue of $409268.0 for Q2 2025, up 19.93% on a QoQ basis from $341264.0 in Q1 2025, and up 84.78% year-over-year from $221484.0 in Q2 2024.

Femasys (FEMY) Revenue (2020 - 2025) Analysis & Trends

Femasys' Revenue history runs 6 years deep, the most recent figure standing at $409268.0 for Q2 2025.

  • Quarterly Revenue rose 84.78% year-over-year to $409268.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.9 million (up 98.61% YoY) and the FY2025 annual result came in at $2.3 million, up 40.77% from the prior year.
  • Revenue was $409268.0 for Q2 2025 at Femasys, up from $341264.0 in the prior quarter.
  • Across five years, Revenue topped out at $581576.0 in Q4 2024 and bottomed at $213111.0 in Q4 2023.
  • A 5-year average of $324306.5 and a median of $311813.5 in 2022 frame the typical range for Revenue.
  • Peak annual rise in Revenue reached 172.9% in 2024, while the deepest fall reached 30.9% in 2024.
  • Femasys' Revenue stood at $254327.0 in 2021, then dropped by 7.9% to $234244.0 in 2022, then declined by 9.02% to $213111.0 in 2023, then surged by 172.9% to $581576.0 in 2024, then slipped by 29.63% to $409268.0 in 2025.
  • Business Quant data shows FEMY's Revenue at $409268.0 in Q2 2025, $341264.0 in Q1 2025, and $581576.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alcon 33,163,703.85 Bn 33,163,702.19 Bn 1.53 Bn 2.69 Bn
2 Intuitive Surgical 119.67 Bn 114.45 Bn 1.96 Bn 2.89 Bn
3 Becton Dickinson 43.92 Bn 43.11 Bn 2.15 Bn 4.71 Bn
4 Medline 31.71 Bn 29.47 Bn 1.84 Bn 7.35 Bn
5 Resmed 28.46 Bn 26.80 Bn 890.98 Mn 1.43 Bn
6 West Pharmaceutical Services 23.80 Bn 23.28 Bn 296.40 Mn 844.90 Mn
7 Cooper Companies 13.77 Bn 13.63 Bn 735.40 Mn 1.08 Bn
8 Solventum 13.63 Bn 13.06 Bn 1.10 Bn 2.01 Bn
9 Align Technology 11.94 Bn 10.88 Bn 736.59 Mn 1.04 Bn
10 Femasys 17.09 Mn 11.70 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 409,268.00
Mar 31, 2025 341,264.00
Dec 31, 2024 581,576.00
Sep 30, 2024 554,908.00
Jun 30, 2024 221,484.00
Mar 31, 2024 271,140.00
Dec 31, 2023 213,111.00
Sep 30, 2023 244,361.00
Jun 30, 2023 320,514.00
Mar 31, 2023 293,984.00
Dec 31, 2022 234,244.00
Sep 30, 2022 347,456.00
Jun 30, 2022 303,113.00
Mar 31, 2022 321,405.00
Dec 31, 2021 254,327.00
Sep 30, 2021 269,581.00
Jun 30, 2021 326,006.00
Mar 31, 2021 329,775.00
Dec 31, 2020 280,964.00
Sep 30, 2020 313,208.00